Paul Knaapen

Showing 1-6 of 6 articles

Coronary interventions

Association between Coronary Collaterals and Myocardial Viability in Patients with a Chronic Total Occlusion

Schumacher S, Everaars H, Stuijfzand W, Huynh JW, van Diemen PA, Bom MJ, de Winter RW, van Loon RB, Van de Ven P, van Rossum A, Opolski MP, Nap A, Knaapen P

March 3, 2020 | 10.4244/EIJ-D-19-01006

Coronary interventions

Relationship between Extent of Ischaemic Burden and Changes in Absolute Myocardial Perfusion after Chronic Total Occlusion Percutaneous Coronary Intervention

Schumacher S, Kockx M, Stuijfzand W, Driessen R, van Diemen PA, Bom MJ, Everaars H, Raijmakers P, Boellaard R, van Rossum A, Opolski MP, Nap A, Knaapen P

September 24, 2019 | 10.4244/EIJ-D-19-00631

Coronary interventions

Comprehensive physiological evaluation of epicardial and microvascular coronary domains using vascular conductance and zero flow pressure

van der Hoeven NW, de Waard G, Quirós A, de Hoyos A, Broyd C, Nijjer S, van de Hoef T, Petraco R, Driessen R, Mejía-Rentería H, Kikuta Y, Pinto M, Van de Ven P, Meuwissen M, Knaapen P, Piek J, Davies J, van Royen N, Escaned J

February 7, 2019 | 10.4244/EIJ-D-18-00021

Coronary interventions

Effects of successful percutaneous coronary intervention of chronic total occlusions on myocardial perfusion and left ventricular function

Stuijfzand W, Biesbroek P, Raijmakers P, Driessen R, Schumacher S, van Diemen PA, van den Berg J, Nijveldt R, Lammertsma A, Walsh S, Hanratty C, Spratt J, van Rossum A, Nap A, van Royen N, Knaapen P

June 20, 2017 | 10.4244/EIJ-D-16-01014

Coronary interventions

Non-invasive assessment of the collateral circulation in the hand: validation of the Nexfin system and relation to clinical outcome after transradial catheterisation

Hollander M, van Leeuwen M, van der Heijden D, Keizer V, Van de Ven P, IJsselmuiden S, Van Mieghem N, Amoroso G, Ritt M, Knaapen P, van Royen N

February 20, 2017 | 10.4244/EIJ-D-16-00337

Coronary interventions

Evaluation of myocardial blood flow and coronary flow reserve after implantation of a bioresorbable vascular scaffold versus metal drug-eluting stent: an interim one-month analysis of the VANISH trial

Stuijfzand W, Raijmakers P, Driessen R, Lammertsma A, van Rossum A, Nap A, Appelman Y, Lemkes J, van Leeuwen M, van Royen N, Knaapen P

August 5, 2016 | 10.4244/EIJV12I5A98

1

Latest news

LM revascularisation, annulus rupture, risk stratification, renal denervation

EAPCI survey results: The impact of COVID-19

Marco Roffi, Dariusz Dudek, et al.

A perspective from EAPCI Women and Women as One

Gill Louise Buchanan

Last Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

Guidance Papers

Guidelines, consensus & position papers

EuroIntervention new Editorial Board

This week’s JAA’s: Paradigm Study: 12months outcome, GLASSY ACS vs SIHD...

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke